3,4,5-trihydroxybenzohydroxamic acid has been researched along with Experimental Hepatoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elford, HL; van't Riet, B; Wampler, GL | 1 |
| Ban, J; Olah, E; Weber, G | 1 |
| Boldizsár, M; Kremmer, T; Oláh, E | 1 |
3 other study(ies) available for 3,4,5-trihydroxybenzohydroxamic acid and Experimental Hepatoma
| Article | Year |
|---|---|
Synthesis of hydroxy- and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activity.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Hydroxamic Acids; Hydroxyurea; In Vitro Techniques; Leukemia L1210; Liver Neoplasms, Experimental; Mice; Ribonucleotide Reductases; Structure-Activity Relationship | 1979 |
Cytotoxic and cell kinetic effects of 3,4,5-trihydroxybenzohydroxamic acid (VF 122) in hepatoma 3924A cells.
Topics: Animals; Cell Cycle; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Hydroxamic Acids; Hydroxyurea; Kinetics; Liver Neoplasms, Experimental; Rats | 1982 |
Potentiation of antimetabolite action by dibromodulcitol in cell culture.
Topics: Amides; Animals; Antimetabolites, Antineoplastic; Cell Division; Cell Line; Drug Synergism; Hydroxamic Acids; Isoxazoles; Liver Neoplasms, Experimental; Mitolactol; Pyrazoles; Rats; Ribavirin; Ribonucleosides; Ribose | 1985 |